Evidence map›Paper›PMID 9343195›Full record

ArticleJournal of virology1997

Virus-specific, CD8+ major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice.

D G Quinn, A J Zajac, C E Hioe, J A Frelinger

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

D G QuinnDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois 60153, USA.
A J Zajac
C E Hioe
J A Frelinger
Loyola University Chicago · US

Funding

GENETICS AND FUNCTION OF MURINE IA ANTIGENSR01AI020288 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI FRELINGER, JEFFREY A. · 1985 to 2001
$614k
GENETICS AND FUNCTION OF MURINE IA ANTIGENSR37AI020288 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI FRELINGER, JEFFREY A. · 1988 to 1995
–
NIAID NIH HHS AI 20288
6 · The paper itself

Abstract

Following infection with lymphocytic choriomeningitis virus (LCMV), normal adult mice generate virus-specific, major histocompatibility complex (MHC) class I-restricted cytotoxic T lymphocytes (CTL) which clear the virus after intraperitoneal infection or cause death following intracranial (i.c.) infection. We have investigated the response of beta2-microglobulin-deficient (beta2m-) mice of the H-2d haplotype (KOD mice) to LCMV infection. Unlike H-2b beta2m- mice, which generate CD4+ MHC class II-restricted CTL in response to LCMV, KOD mice generate high levels of CD8+ MHC class I-restricted, virus-specific CTL. These CTL are specific for the LCMV nucleoprotein epitope (residues 118 to 126) in association with the Ld class I molecule, analogous to the CTL response in wild-type mice. KOD mice are also susceptible to lethal LCM disease, with 75 to 80% of the mice dying 7 to 9 days following i.c. infection with virus. Similar to results with normal mice, lethal LCM disease in KOD mice is prevented by in vivo depletion of CD8+ T cells prior to i.c. infection. In contrast to wild-type mice, however, KOD mice cannot control LCMV and become persistently infected. Overall, these results demonstrate that beta2m is not an absolute requirement for presentation of endogenous antigen on Ld or for induction of virus-specific Ld-restricted CTL in vivo.

Indexed as

AnimalsAntigens, Viralbeta 2-MicroglobulinCD8-Positive T-LymphocytesFemaleH-2 AntigensLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMaleMiceMice, Inbred BALB CMice, KnockoutNucleoproteinsPeptide FragmentsT-Lymphocytes, CytotoxicAntigens, Viralbeta 2-MicroglobulinH-2 Antigensnucleoprotein peptide 118-126, lymphocytic choriomeningitis virusNucleoproteinsPeptide Fragments

Identifiers

PMID9343195
PMCPMC192301
OpenAlexW2134292196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.